Qiagen NV | QIA - Equity Capital And Reserves

Stock Price
43.17
Daily Change
-0.31 -0.70%
Monthly
1.90%
Yearly
8.86%
Q1 Forecast
43.53

Qiagen NV reported $3.65B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
argenx SE USD 6.1B 597.47M Jun/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Moderna USD 9.33B 69M Sep/2025
Organon & Co USD 906M 173M Sep/2025
Qiagen NV USD 3.65B 143.93M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025